Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Anemia

Free Subscription Articles published in Nephrol Dial Transplant Retrieve available abstracts of 26 articles: HTML format

Single Articles

April 2023
1. SARNAK MJ, Agarwal R, Boudville N, Chowdhury PCP, et al
   Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis.
   Nephrol Dial Transplant. 2023 Apr 24:gfad074. doi: 10.1093.
   PubMed     Abstract available
   
   
   February 2023
2. ITO S, Hataya H, Ashida A, Hamada R, et al
   Eculizumab for paediatric patients with atypical haemolytic uraemic syndrome: full dataset analysis of post-marketing surveillance in Japan.
   Nephrol Dial Transplant. 2023;38:414-424.
   PubMed     Abstract available
   
   
   
3. TER AVEST M, Bouwmeester RN, Duineveld C, Wijnsma KL, et al
   Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effective.
   Nephrol Dial Transplant. 2023;38:362-371.
   PubMed     Abstract available
   
   
   January 2023
4. CHENG Y, Xiang Q, Cao T, Tang F, et al
   Suppression of thyroid profile during roxadustat treatment in chronic kidney disease patients.
   Nephrol Dial Transplant. 2023 Jan 20:gfad017. doi: 10.1093.
   PubMed    
   
   
   October 2022
5. PERKOVIC V, Blackorby A, Cizman B, Carroll K, et al
   The ASCEND-ND trial: study design and participant characteristics.
   Nephrol Dial Transplant. 2022;37:2157-2170.
   PubMed     Abstract available
   
   
   August 2022
6. CAVERO T, Aunon P, Caravaca-Fontan F, Trujillo H, et al
   Thrombotic microangiopathy in patients with malignant hypertension.
   Nephrol Dial Transplant. 2022 Aug 24. pii: 6674778. doi: 10.1093.
   PubMed     Abstract available
   
   
   September 2021
7. FAIVRE A, Scholz CC, de Seigneux S
   Hypoxia in chronic kidney disease: towards a paradigm shift?
   Nephrol Dial Transplant. 2021;36:1782-1790.
   PubMed     Abstract available
   
   
   July 2021
8. BESARAB A, Drueke TB
   The problem with transferrin saturation as an indicator of iron 'sufficiency' in chronic kidney disease.
   Nephrol Dial Transplant. 2021;36:1377-1383.
   PubMed     Abstract available
   
   
   
9. LOCATELLI F, Del Vecchio L, De Nicola L, Minutolo R, et al
   Are all erythropoiesis-stimulating agents created equal?
   Nephrol Dial Transplant. 2021;36:1369-1377.
   PubMed     Abstract available
   
   
   June 2021
10. BARRATT J, Andric B, Tataradze A, Schomig M, et al
    Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a phase 3, randomised, open-label, active-controlled study (DOLOMITES).
    Nephrol Dial Transplant. 2021 Jun 2. pii: 6291250. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2021
11. LOCATELLI F, Del Vecchio L
    A new paradigm in treating patients with chronic kidney disease and anaemia after a journey lasting more than 35 years.
    Nephrol Dial Transplant. 2021 May 20. pii: 6278901. doi: 10.1093.
    PubMed    
    
    
    
12. AYERDEM G, van Hassel G, Vinke JSJ, Kremer DJ, et al
    Iron deficiency, with and without anemia, across strata of kidney function in kidney transplant recipients.
    Nephrol Dial Transplant. 2021 May 3. pii: 6263840. doi: 10.1093.
    PubMed    
    
    
    March 2021
13. SINGH AK, Blackorby A, Cizman B, Carroll K, et al
    Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial.
    Nephrol Dial Transplant. 2021 Mar 21. pii: 6179323. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2021
14. NANGAKU M, Kondo K, Ueta K, Kokado Y, et al
    Efficacy and safety of vadadustat compared with darbepoetin alfa in japanese anemic patients on hemodialysis: A phase 3, multicenter, randomized, double-blind study.
    Nephrol Dial Transplant. 2021 Feb 26. pii: 6154307. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. SHUTOV E, Sulowicz W, Esposito C, Tataradze A, et al
    Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a phase 3, randomized, double-blind, placebo-controlled study (ALPS).
    Nephrol Dial Transplant. 2021 Feb 25. pii: 6149483. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. PROVENZANO R, Shutov E, Eremeeva L, Korneyeva S, et al
    Roxadustat for anemia in patients with end-stage renal disease incident to dialysis.
    Nephrol Dial Transplant. 2021 Feb 25. pii: 6149078. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. GUEDES M, Muenz D, Zee J, Lopes MB, et al
    Serum biomarkers of iron stores are associated with worse physical health-related quality of life (HRQoL) in non-dialysis dependent chronic kidney disease (NDD-CKD) patients with or without anemia.
    Nephrol Dial Transplant. 2021 Feb 24. pii: 6149131. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. GOTTA V, Tancev G, Marsenic O, Vogt JE, et al
    Identifying key predictors of mortality in young patients on chronic haemodialysis-a machine learning approach.
    Nephrol Dial Transplant. 2021;36:519-528.
    PubMed     Abstract available
    
    
    January 2021
19. HODSON EM, Strippoli GFM
    Long- or short-acting erythropoiesis-stimulating agents: take no shortcuts in their evaluation.
    Nephrol Dial Transplant. 2021;36:205-207.
    PubMed    
    
    
    December 2020
20. MONET-DIDAILLER C, Chevallier A, Godron-Dubrasquet A, Allard L, et al
    Outcome of children with Shiga toxin-associated haemolytic uraemic syndrome treated with eculizumab: a matched cohort study.
    Nephrol Dial Transplant. 2020;35:2147-2153.
    PubMed     Abstract available
    
    
    November 2020
21. ECKARDT KU, Agarwal R, Farag YM, Jardine AG, et al
    Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO2VATE trials.
    Nephrol Dial Transplant. 2020 Nov 14. pii: 5981973. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2020
22. ZHENG Q, Yang H, Fu X, Huang Y, et al
    The efficacy and safety of roxadustat for anemia in patients with chronic kidney disease: a meta-analysis.
    Nephrol Dial Transplant. 2020 Oct 14. pii: 5923003. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2020
23. MINUTOLO R, Garofalo C, Chiodini P, Aucella F, et al
    Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease.
    Nephrol Dial Transplant. 2020 Aug 23. pii: 5896177. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2020
24. FLOEGE J, Funk F, Ketteler M, Rastogi A, et al
    Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammation.
    Nephrol Dial Transplant. 2020;35:946-954.
    PubMed     Abstract available
    
    
    February 2020
25. BHANDARI S, Kalra PA, Berkowitz M, Belo D, et al
    Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial.
    Nephrol Dial Transplant. 2020 Feb 12. pii: 5734687. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2019
26. LOCATELLI F, Del Vecchio L
    Are prolyl-hydroxylase inhibitors potential alternative treatments for anaemia in patients with chronic kidney disease?
    Nephrol Dial Transplant. 2019 Mar 7. pii: 5371147. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.